Evidence map›Paper›PMID 37952957›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Successful Treatment of Diffuse Large B-cell Lymphoma Involving Multiple Renal and Bone Infiltrations Presenting with Giant Cell Arteritis-like Manifestations.

Kazuhiro Yokota, Kota Morimoto, Hiroaki Yazawa, Takuma Tsuzuki Wada, Tomoyuki Sakamoto, Yasuhito Terui, Satoru Kaneko, Tsutomu Inoue, Hirokazu Okada, Yuji Akiyama and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kazuhiro YokotaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Kota MorimotoDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Hiroaki YazawaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Takuma Tsuzuki WadaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Tomoyuki SakamotoDepartment of Hematology, Faculty of Medicine, Saitama Medical University, Japan.
Yasuhito TeruiDepartment of Hematology, Faculty of Medicine, Saitama Medical University, Japan.
Satoru KanekoDepartment of Nephrology, Faculty of Medicine, Saitama Medical University, Japan.
Tsutomu InoueDepartment of Nephrology, Faculty of Medicine, Saitama Medical University, Japan.
Hirokazu OkadaDepartment of Nephrology, Faculty of Medicine, Saitama Medical University, Japan.
Yuji AkiyamaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Toshihide MimuraDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Saitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of diffuse large B-cell lymphoma (DLBCL) involving multiple renal and bone infiltrations presenting with giant cell arteritis (GCA)-like manifestations. One month prior, the present patient had left-sided temporal headache, jaw claudication, and renal failure. The patient was diagnosed with DLBCL based on a renal biopsy. After rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone plus intrathecal methotrexate/cytarabine/prednisone and rituximab, high-dose methotrexate, and cytarabine chemotherapy, the patient's clinical manifestations improved, and complete remission was achieved. DLBCL rarely but occasionally presents with GCA-like manifestations or multiple renal and bone infiltrations, highlighting the need for prompt and aggressive combination chemotherapy.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsGiant Cell ArteritisLymphoma, Large B-Cell, DiffuseCyclophosphamideDoxorubicinHumansKidney NeoplasmsPrednisoneRituximabTreatment OutcomeVincristineCyclophosphamideDoxorubicinPrednisoneRituximabVincristinebone infiltrationdiffuse large B-cell lymphomafluorodeoxyglucose-positron emission tomography/computed tomographygiant cell arteritisrenal failure

Identifiers

PMID37952957
PMCPMC11189708
OpenAlexW4388608680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.